Morning Overview on MSN
A common diabetes drug just showed it can slow the aging process itself in a major trial — hinting at a cheap pill that targets aging head-on
Metformin costs about five cents a pill. More than 150 million people worldwide swallow it every day to manage type 2 ...
Any striking marketing claims in companies’ ads about the gut benefits of a popular probiotic may be full of, well, the same thing that has their target audience backed up. The study adds to a mixed ...
In the 1940s, medical researchers began using randomized controlled trials to assess the efficacy of health interventions. In ...
CAMBRIDGE, MA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- EyeCool Therapeutics today announced the publication ...
Background Hearing loss (HL) imposes a substantial burden on families and society and is the largest modifiable risk factor ...
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key ...
Results of a multisite randomized trial of Bright IDEAS-Young Adults: Efficacy of problem-solving skills training on distress and health-related quality of life. This is an ASCO Meeting Abstract from ...
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...
The study concluded that NEXGEL’s hydrogel patch significantly reduced laser plume generation and exposure during laser hair removal and the ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results